Ayati N, Layeghi-Ghalehsoukhteh S, Esteghamati A. Cost-effectiveness of Empagliflozin Compared to Liraglutide in Iran Based on Cardiovascular Outcome Trials in Type 2 Diabetes Mellitus. JPPM. 2022;8(1/2):24-30.